Related Experiment Videos

Pseudomonas aeruginosa as a cause of infectious diarrhoea

P A Adlard1, S M Kirov, K Sanderson

  • 1Division of Pathology, University of Tasmania, Hobart, Australia.

Epidemiology and Infection
|September 25, 1998
PubMed

Insights

Pseudomonas aeruginosa, typically not a cause of diarrhea, was found in hospitalized patients with persistent diarrhea. This study suggests it can cause enteritis, especially in immunocompromised individuals.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Gastroenterology

Background:

  • Pseudomonas aeruginosa is rarely implicated in infectious diarrhea.
  • Persistent diarrhea in hospital outpatients often lacks a clear enteropathogen.
  • This study investigated P. aeruginosa as a potential cause of prolonged diarrhea.

Purpose of the Study:

  • To determine the etiological role of Pseudomonas aeruginosa in patients with persistent diarrhea.
  • To assess the virulence factors of P. aeruginosa isolates from these patients.
  • To evaluate the potential of P. aeruginosa to cause intestinal infections.

Main Methods:

  • Patient histories were reviewed for 23 hospital outpatients with persistent diarrhea.
  • Faecal isolates of P. aeruginosa were tested for in vitro virulence (adherence, motility, cytotoxicity).
  • In vivo studies included infant mice (enterotoxicity) and clindamycin-pretreated rats (intestinal colonization and enteritis).

Main Results:

  • No other enteropathogen was identified in 20 of the 23 patients.
  • Over 40% of P. aeruginosa isolates showed HEp-2 cell adherence and twitching motility.
  • More than 80% of isolates produced cytotoxic activity; some were weakly enterotoxigenic in mice.
  • Two isolates caused persistent enteritis in rats.

Conclusions:

  • Pseudomonas aeruginosa possesses virulence factors suggesting intestinal colonization capability.
  • The bacterium demonstrated cytotoxic and enterotoxigenic potential in vitro and in vivo.
  • These findings indicate P. aeruginosa can cause infectious diarrhea, particularly in immunocompromised patients.

Related Concept Videos